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Abstract
Objective-To evaluate dynamic contrast
enhanced computed tomography for detecting and
localising pancreatic necrosis in acute pancreatitis.
Design-Prospective evaluation with blind report-
ing of scans.
Setting-Single teaching hospital.
Patients-60 Consecutive patients with acute
pancreatitis suspected to have pancreatic necrosis
because of major organ system failure (13); slow
recovery five to seven days after admission with
raised scores on the acute physiological and chronic
health evaluation (APACHE-II) system (27); or
findings on previous ultrasonography or computed
tomography (20).
Main outcome measure-Pancreatic necrosis
proved histologically-that is, >30 g necrotic tissue
debrided at laparotomy (for life threatening sepsis or
peritonitis) or necropsy.
Results-Dynamic computed tomography
correctly localised pancreatic necrosis in 11 patients
(confirmed at laparotomy in nine and at necropsy in
two). Of nine patients with low enhancement of
peripancreatic tissues alone, eight recovered after
conservative management; necropsy confirmed
viable pancreas and necrosis of peripancreatic fat in
one patient. Of 40 patients with normal contrast
enhancement, none required laparotomy to debride
pancreatic necrosis.
Conclusion-Dynamic contrast enhanced com-
puted tomography seems to be a safe and accurate
method of identifying and localising pancreatic and
FIG 1-Matched computed tomograms before (left) and after (right) administration ofintravenous contrast,
shounng increased density ofnormal pancreas and other perfused structures
peripancreatic necrosis, which cannot be predicted
accurately by conventional imaging techniques.
Introduction
Fatal acute pancreatitis is often associated with
septic complications of pancreatic necrosis,' 2 which we
define as a collection of solid necrotic tissue3 rather
than pus (pancreatic abscess) or pancreatic juice
(pseudocyst). Collections of pus and pancreatic juice
are associated with lower morbidity and mortality.45
Survival of patients with pancreatic necrosis often
depends on surgical debridement of necrotic tissue.246
Before surgery the presence and extent of pancreatic
necrosis must be identified. This cannot be achieved by
clinical assessment,7 laboratory criteria,79 or ultrasono-
graphy,"'0 and even at laparotomy surgeons cannot
differentiate accurately between necrotic and viable
tissue" or between necrotic pancreas and necrotic
peripancreatic fat. 2
Computed tomography shows characteristic
changes in pancreatic and peripancreatic tissues during
acute pancreatitis,'3"14 and although a correlation with
outcome has been shown,'3 151 6 the extent to which the
results of computed tomography are prognostic is
disputed. 'I-" The pancreas is richly vascularised and its
density in computed tomograms is considerably
increased, or enhanced, after patients have been given
intravenous contrast medium (fig 1). The enhancement
is measured by calculating the increase in density in
defined areas. Kivisaari et al evaluated contrast
enhanced computed tomography in 29 patients who
had pancreatectomy for fulminant pancreatitis.20
Enhancement was less than 30 Hounsfield units in
21 patients with pancreatic necrosis but exceeded
40 Hounsfield units in eight patients with oedematous
pancrfeatitis. Slow scanning times (10 seconds) and
a single scanning level, however, made accurate
localisation impossible. -Multiple level scanning has
also been evaluated8: five of 62 patients with low
enhancement did not have pancreatic necrosis, and 10
of 15 patients with normal enhancement had substantial
necrosis. Scanning times of 5-10 seconds may have
precluded precise evaluation.
Modern computed tomographic scanners, which
have improved resolution, shorter scanning times, and
dynamic scanning modes, allow sequential scans to be
obtained rapidly. Non-ionic contrast media have mini-
mised renal and cardiovascular complications'. We
examined a technique that incorporated these advances
-and report on its performance in identifying and
localising pancreatic necrosis in acute pancreatitis.
Patients and methods
All the patients had been admitted to hospital with a
clinical diagnosis of acute pancreatitis and had plasma
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amylase activities >1200 IU/l (Phadebas, Pharmacia,
Milton Keynes). Patients had dynamic computed
tomography if pancreatic necrosis was suspected
because of major organ system failure (box); slow
recovery five to seven days after admission, with scores
on the acute physiological and chronic health evaluation
system (APACHE-II) -822; or evidence of severe
pancreatitis on ultrasonography or tomography
taken before referral suggesting severe pancreatitis.
Predictions of pancreatic necrosis based on dynamic
computed tomograms were confirmed if histological
examination of tissue obtained by laparotomy or
necropsy showed more than 30 g necrotic tissue.3
Indications for surgery were based not onthe results of
computed tomography but on increasing sepsis or
signs of peritonitis. Patients who died had necropsies,
and survivors were followed up for 15 to 43 months
(median 30 months).
We used a CT-9800 scanner (IGE Medical Systems,
Slough) with a dynamic facility, which permitted
detailed imaging of pancreatic and peripancreatic
tissues during the brief period of enhancement after
bolus injection of contrast medium.20 Before scanning,
500-750 ml of 3% Gastrografin solution (10% sodium
diatrizoate, 66% meglumine diatrizoate; Schering
Pharmaceuticals, Burgess Hill) was given to each
patient either orally or through a nasogastric tube.
Scans of 10 mm thickness were obtained every 20 mm
from the domes of the diaphragm caudally. Scanning
levels for contrast enhanced computed tomography
were selected, and a rapid sequence of 10-14 contiguous
or alternate 5 mm sections was obtained immediately
after intravenous injection of 100-150 ml of 76%
iopamidol (Niopam 370, E Merck, Alton; equivalent
to a dosage of 500-750 mg iodine/kg) over 30 to
75 seconds. Patients were scanned at end expiration
for two seconds with a six second delay between
scans to permit respiration. After reconstruction
contrast enhancement was assessed throughout the
pancreas and peripancreatic tissues. As in previous
studies enhancement of less than 30 Hounsfield units
was considered abnormal, enhancement exceeding
40 Hounsfield units was considered, normal, and
enhancement of 30-40 Hounsfield units was considered
equivocal.2023 The results oftomography were analysed
immediately by a single consultant radiologist, who
commented on enhancement of peripancreatic tissues
and the pancreatic head, body, and tail.
FIG 2-Matched computed tomograms ofpatient who subsequently had debridement ofnecrotic body and tail
ofpancreas. Tomogram obtained before contrast was administered (left) shows diffuse pancreatic swelling
and peripancreatic inflammation, whereas that obtained afterwards (right) shows minimal enhancement of
body and no enhancement ofthe tail, both ofwhich were necrotic
Definitions of major organ system failure
Arterial hypoxia-Arterial oxygen pressure <8
kPa necessitating >24 hours' oxygen treatment or
ventilation
Renal failure-Mean urine volume <20 ml/h for
24 h
Refractory hypotension-Systolic blood pressure
<100 mm Hg despite administration of pressor
agents
Coagulopathy-Prothrombin time, activated
partial thromboplastin time, or thrombin time
exceeding twice control values; or platelet count
<20x 109/1; or fibrinogen concentration <1 g/l; or
concentration of fibrinogen degradation products
exceeding twice normal value
Results
Sixty patients fulfilled our selection criteria during
April 1986 to June 1988: 13 had major organ system
failure, 27 had a slow recovery with raised APACHE-II
scores, and 20 had had severe disease on previous
imaging. During the study 109 other patients were
admitted to the hospital with acute pancreatitis but did
not have computed tomography. None of them
required laparotomy for pancreatic necrosis.
Computed tomography was performed between one
hour and seven days (median three days) after admis-
sion to hospital. Eleven patients had areas of abnormal
pancreatic enhancement. Pancreatic necrosis was con-
firmed either at laparotomy (nine patients) or at
necropsy (two). Of the 11 patients, six had necrosis
restricted to the pancreas (fig 2) and five had pancreatic
and peripancreatic necrosis. In all cases the anatomical
distribution of necrosis precisely matched that
indicated by dynamic computed tomography (table).
Relation between radiological evidence ofpancreatic enhancement and
findings at laparotomy or necropsy. Values are numbers ofpatients
Pancreatic necrosis
Patients with contrast confirmed by:
enhancement <30
Area of pancreas Hounsfield units Laparotomy Necropsy
Head, body, or tail 6 5 1
Head and body
Body and tail




A further nine patients had normal pancreatic enhance-
ment but abnormal peripancreatic enhancement (fig 3
(top)): eight recovered after conservative management
and peripancreatic necrosis could not be confirmed;
one patient died and peripancreatic necropsy confirmed
a viable pancreas with necrosis of peripancreatic fat
(fig 3 (bottom)).
Of the remaining 40 patients, 36 had normal
enhancement throughout and four had equivocal pan-
creatic enhancement initially which had returned to
normal on rescanning 48 hours later. All 40 patients
survived without requiring debridement of pancreatic
necrosis, but collections of fluid were drained in 12
(from a pseudocyst in nine and a pancreatic abscess
in three; by percutaneous puncture in five and by
operation in seven). All 12 collections of fluid had been
noted on computed tomography obtained before
administration of contrast medium.
No adverse cardiac or renal effects were noted
during 134 dynamic computed tomographic examina-
tions in the 60 patients. One patient vomited while
receiving the intravenous contrast medium, and angina
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FIG 3-(Top) Matched computed tomograms obtained before (left) and after (right) administration of
contrast. Tomogram obtained after contrast was given shows rind ofpoorly enhancing tissue surrounding
pancreas anteriorly and inferiorly, which is not visible in scan obtained before contrast was given. (Bottom)
Necropsy specimen from same patient, oriented anatomically and sectioned vertically through midbody of
pancreas. Histological examination confirmed pancreatic viability, but rim of darker tissue, which
corresponded to area oflow enhancement, consisted ofnecrotic fat
was precipitated in another patient; in neither case
were there serious sequelae. Several patients had
watery diarrhoea after scanning.
Discussion
We evaluated a technique of dynamic contrast
enhanced computed tomography'for detecting pan-
creatic necrosis. Patients had to be given contrast
medium orally to delineate the pancreas and peripan-
creatic tissues from the adjacent bowel. The diarrhoea
experienced by some patients probably related to the
high osmolality of this contrast medium as, more
recently, it has been prevented by giving patients a
non-ionic medium (3% iohexol; diluted Omnipaque
350, Nycomed, Birmingham). We used a non-ionic
intravenous contrast medium throughout because
many patients had cardiovascular instability or renal
failure; both are contraindications to giving ionic
media. The high dose of intravenous contrast medium
and rapid injection were essential to sustain enhance-
ment for one to two minutes, the time taken to imnage
the entire pancreatic area with a modern computed
tomographic scanner with a dynamic facility.
Three patterns of abnormal enhancement emerged:
abnormal pancreatic enhancement probably rep-
resents necrosis of devitalised pancreas (central
necrosis); abnormal pancreatic and peripancreatic
enhancement represents extension of necrosis beyond
the gland (extended central necrosis); and abnormal
enhancement of peripancreatic tissue alone represents
necrosis of fat and connective tissue due to exudation of
activated pancreatic enzymes (peripheral necrosis).
Central and extended central necrosis was confirmed
histologically. Peripheral necrosis sometimes appeared
as a "rind" around the pancreas and sometimes as a
crenated or scalloped pattern, suggesting necrosis of
fat in the' periphery of the gland. As the decision to
perform laparotomy was based on clinical progress we
could confirm the pattern of peripheral necrosis only in
the patient who died.
Patients with abnormal or equivocal contrast
enhancement had dynamic computed tomography at
least weekly until surgical or radiological intervention
was undertaken or recovery occurred. The unaided
recovery of four patients with equivocal enhancement
suggests that areas of poorly perfused or ischaemic
pancreas may improve spontaneously provided that
perfusion does not become critically low. No such
improvement was noted in patients with pancreatic
enhancement of less than'30 Hounsfield units, in all of
whom pancreatic necrosis was debrided. Although
abnormal enhancement was often obvious from
inspection of tomograms obtained before and after
the administration of contrast medium, our findings
emphasise the need to quantify enhancement ac-
curately.
Pancreatic enhancement after intravenous adminis-
tration of con'trast medium may be influenced by the
nature and volume of the contrast medium, injection
speed, cardiac output, blood volume, splanchnic per-
fusion, and elimination of the medium from the
circulation. Capillary blood flow was the principal
determinant of enhancement in pigs with acute
pancreatitis,24 and microangiography of human
pancreatectomy specimens confirmed that micro-
circulatory damage in pancreatic necrosis corresponds
with abnormal enhancement.25
A clearer understanding of the pathological evolu-
tion of pancreatic necrosis is now emerging,' 2 452 and
the survival of patients treated in specialist units has
improved,24 6 possibly because patients likely to
require surgical debridement are more accurately
identified.248 3 Pancreatic necrosis may be sterile or
infected,l26 and whereas the patients with infected
necrosis are typically the most severely ill,' sterile
pancreatic necrosis can be lethal.''3 Computed tomo-
graphy cannot differentiate between infected and
sterile necrosis,' but percutaneous aspiration guided
by computed tomography can do so reliably.26
Dynamic contrast enhanced computed tomography
identified and localised pancreatic necrosis precisely
and proved safe when patients were given a non-ionic
intravenous contrast medium. Doubts about safety
will probably persist, but we believe that dynamic
computed tomography should be used when pan-
creatic necrosis is suspected even in severely ill patients
because of the precise information it provides. It did
not indicate when an operation was necessary, but
when surgery was indicated clinically it provided
information that facilitated a less invasive surgical
procedure and ensured that all necrotic tissue was
located and debrided adequately.3
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An endometrial factor in unexplained infertility
R A Graham, M W Seif, J D Aplin, T C Li, I D Cooke, A W Rogers, P Dockery
Abstract
Objective-To study a group of women with
unexplained infertility to see whether they have a
defect that is intrinsic to the endometrium.
Design-Evaluation of the functional response of
the endometrium by examining endometrial biopsy
specimens using immunohistochemical methods in a
group of women with unexplained infertility and in a
control group ofwomen with normal fertility.
Patients-27 Women with unexplained infertility
(average age 33.2); median duration of infertility
five years. A control group of 44 women with normal
fertility (average age 33.8) who were requesting
sterilisation or reversal of sterilisation.
Setting-Infertility clinic, Jessop Hospital for
Women, Sheffield.
Intervention- Secretory phase endometrial
biopsy specimens were taken, with informed consent,
as an outpatient procedure.
Main outcome measures -Immunohistochemistry
with monoclonal antibody D9B1, was used to assess
the production and secretion of an oligosaccharide
epitope produced by endometrial gland cells between
two and seven days after the luteinising hormone
surge. A reflected light measuring system was used
to assess the amount of epitope within the gland
cells, and in the gland lumen.
Results-In the control group of women, mean
reflected light measurements at the cell base and cell
apex peaked at three and five days after the luteinis-
ing hormone surge respectively, and in the gland
lumen the epitope accumulated rapidly from three
days, reaching a peak at seven days. In the women
with infertility the peaks of epitope at the cell base
and cell apex were lower, broader, and delayed in
onset, and the build up of epitope in the gland lumen
was retarded. The synthesis and secretion of the
epitope in the women with infertility was therefore
significantly reduced and delayed, even in the
presence of normal concentrations of circulating
progesterone.
Conclusions-The results suggest that a primary
dysfunction of the endometrium might be associated
with hitherto unexplained infertility.
Introduction
Substantial numbers of patients with unexplained
infertility attend infertility clinics, with reported pre-
valences ranging from 6% to almost 60%.' The hor-
monal profiles of women with unexplained infertility
have been much studied and are often normal, but in
contrast, the endometrium has been comparatively
unexplored as a factor in infertility. This has been
justified by the widespread belief that endometrial
morphology provides no more than a simple and
faithful reflection of the ovarian cycle. The use of the
endometrial biopsy specimen as an index of ovulation
has been largely superseded by non-invasive, quanti-
tative, sensitive, endocrine assays, and failure of the
endometrium to respond fully to a normal ovarian
stimulus has remained hypothetical.
The secretory differentiation of the endometrial
epithelium has been characterised by raising mono-
clonal antibodies to hormonally regulated cell surface
and secretory components." The monoclonal anti-
body D9B1 binds to a peptide associated sialo-
oligosaccharide of the sulphated lactosaminoglycan
family, 6 which is secreted by gland cells mainly
between three and seven days after the luteinising
hormone surge.4 Study of the defective luteal phase has
shown that there is a strong correlation between
infertility and reduced production of the D9B 1
epitope7; this deficiency may occur against a back-
ground of normal secretory differentiation as assessed





R A Graham, BSC, research
assistant
The late A W Rogers, DSC,
formnerly professor








MW Seif, PHD, clinical
tutor





Women, Sheffield S3 7RE
T C Li, PHD, clinical lecturer
I D Cooke, FRCOG, professor
Correspondence to:
Dr J D Aplin, Department
of Obstetrics and
Gynaecology, Research
Floor, St Mary's Hospital,
Manchester M13 OJH.
Br Aled_I 1990;300:1428-31
1428 BMJ VOLUME 300 2 JUNE 1990
